Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

SHSE:603168 Stock Report

Market Cap: CN¥3.0b

Zhejiang Shapuaisi PharmaceuticalLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure4.3yrs

Recent management updates

Recent updates

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHSE:603168) Investors Are Less Pessimistic Than Expected

Aug 23
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHSE:603168) Investors Are Less Pessimistic Than Expected

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.'s (SHSE:603168) Shares May Have Run Too Fast Too Soon

Apr 09
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.'s (SHSE:603168) Shares May Have Run Too Fast Too Soon

CEO

Zhejiang Shapuaisi PharmaceuticalLtd has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Mingxiong Huang
Board Secretary & Director2.8yrsCN¥463.00k0.067%
CN¥ 2.0m
Guotong Xu
Independent Director4.3yrsCN¥100.00kno data
Weimin Wang
Director14.6yrsCN¥7.00kno data
Yuanlue Fu
Independent Director4.3yrsCN¥100.00kno data
Xiao Feng
Employee Supervisor9.5yrsno datano data
Jianguo Wu
Director4.3yrsCN¥379.20k0.027%
CN¥ 792.0k
Jiwei Sun
Independent Director1.9yrsCN¥96.60kno data
Kai Lin
Director1.5yrsCN¥298.40k0.027%
CN¥ 792.0k

4.3yrs

Average Tenure

58.5yo

Average Age

Experienced Board: 603168's board of directors are considered experienced (4.3 years average tenure).